Alkermes (ALKS) Opens Dublin HQ, Enters Large Manufacturing Agreement
September 19, 2011
Alkermes plc Launches Corporate Operations in Ireland
September 19, 2011
Alkermes (ALKS), Elan Complete $1B Cash and Stock Merger
September 16, 2011
Data Announced On Bydureon
September 13, 2011
Alkermes, Inc. (NASDAQ:ALKS), Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) and Eli Lilly and Company (NYSE:LLY) recently announced new analyses of data from the DURATION 3 and DURATION 4 trials which... Read More
from DailyMarkets.com
Lilly, Amylin, Merck Diabetes Drug Risks Highlighted
September 13, 2011
Amylin (AMLN), Alkermes (ALKS), Lilly (LLY) Report Strong Data from BYDUREON DURATION-3 and -4
September 12, 2011
Analyses Find Type 2 Diabetes Patients Treated with BYDUREON™ Experienced Reduction in Cardiovascular Risk Factors: Results Presented at EASD 2011
September 12, 2011
from PR Newswire
Alkermes’ Corporate Presentation to be Webcast at Two Upcoming Conferences
September 07, 2011
(ALKS) Alkermes Analyst Maintains Neutral Rating on Shares
September 01, 2011
We are maintaining our Neutral recommendation on Alkermes, Inc. (ALKS). Alkermes is a drug delivery... Visit StockBlogHub to view complete post. Read More
from Stock Blog Hub
Risk Reward Balances Alkermes
August 31, 2011
We are maintaining our Neutral recommendation on Alkermes, Inc. (NASDAQ:ALKS). Alkermes is a drug delivery biotech company which uses its proprietary specialized drug delivery technologies to develop... Read More
from DailyMarkets.com
Caris & Co. Upgrades Alkermes (ALKS) to Buy
August 30, 2011
Alkermes (ALKS): Upgraded by UBS
August 24, 2011
Wall Street Analyst Actions 08-23-11
August 23, 2011
category
Analyst/Actions
from Wall Street Greek
Up/Downgrades (AET, ALKS, CNP, CYN, COH, HWAY, JNPR, LNN, NRG, PWRD, SAFM, HRL, LNCR, PEG, STP)
August 23, 2011
New York, August 23rd (TradersHuddle.com) – Following are some of the top upgrades and downgrades before the market open. Upgrades Aetna (<a href="http://www.trad. Read More -- Read More
from TradersHuddle.com
UBS Upgrades Alkermes (ALKS) to Buy
August 23, 2011
Biotech analysts see plunge as buying opportunity
August 12, 2011
While most investors fled for safer havens this week, biotech analysts were advising clients to take advantage of discounted stock prices. Read More
from MarketWatch
BYDUREON™ FDA Action Date Set for January 28, 2012
August 10, 2011
BYDUREON™ FDA ACTION DATE SET FOR JANUARY 28, 2012
August 10, 2011
from PR Newswire
The Zacks Analyst Blog Highlights: Alkermes, Johnson & Johnson, Amylin Pharmaceuticals, Eli Lilly and Company and Elan Corporation
August 04, 2011
from PR Newswire
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here